Our investigation aimed at evaluating the relationship between metabolic syndrome, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma glutamyl transferase (GGT), and alkaline phosphatase (ALP) in the Rafsanjan cohort study (RCS). We used data obtained from the RCS, as a part of the prospective epidemiological research studies in Iran. In this cross-sectional research, 9895 participants from the baseline phase of RCS who completed medical questionnaire were included. Metabolic syndrome (MetS) defined using NCEP-ATP III criteria. The relationship between elevated serum liver enzymes levels even within the normal range and metabolic syndrome was evaluated by logistic regressions. The prevalence of MetS was 34.42% in the participants of study. The mean concentrations of AST, ALT, ALP, and GGT increased with increasing MetS components. After adjusting for all potential confounders, elevated serum concentrations of ALT, AST, GGT, and ALP even within the normal range were related with an increased odds of MetS. MetS was associated with increased levels of liver enzymes even within the normal range. These results indicated the potential for elevated liver enzymes as biomarkers for the possible presence of MetS.
SidorenkovONilssenOGrjibovskiAM.Metabolic syndrome in Russian adults: associated factors and mortality from cardiovascular diseases and all causes. BMC Public Health2010; 10(1): 1–10.
2.
ObeidatAAAhmadMNHaddadFH, et al. Alarming high prevalence of metabolic syndrome among Jordanian adults. Pak J Med Sci2015; 31(6): 1377.
3.
BaharAKashiZKheradmandM, et al. Prevalence of metabolic syndrome using international diabetes federation, National Cholesterol Education Panel-Adult Treatment Panel III and Iranian criteria: results of Tabari cohort study. J Diabetes Metab Disord2020; 19(1): 205–211.
4.
FarmanfarmaKKKaykhaeiMAAdinehHA, et al. Prevalence of metabolic syndrome in Iran: a meta-analysis of 69 studies. Diabetes Metab Syndr2019; 13(1): 792–799.
5.
ChenSGuoXYuS, et al. Metabolic syndrome and serum liver enzymes in the general chinese population. Int J Environ Res Public Health2016; 13(2): 223.
6.
IslamSRahmanSHaqueT, et al. Prevalence of elevated liver enzymes and its association with type 2 diabetes: a cross-sectional study in Bangladeshi adults. Endocrinol Diabetes Metab2020; 3(2): e00116.
7.
SunithaSGandhamRWilmaD, et al. Evaluation of significance of liver enzymes as screening tests for the early detection of clinically asymptomatic non alcoholic fatty liver disease in type 2 diabetes mellitus patients. Int J Biomed Adv Res2015; 6(12): 860–863.
8.
AmirkalaliBPoustchiHKeyvaniH, et al. Prevalence of non-alcoholic fatty liver disease and its predictors in north of Iran. Iran J Public Health2014; 43(9): 1275.
9.
HanA.Association of cardiovascular risk factors and metabolic syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis. BMC Endocr Disord2021; 21(1): 1–8.
10.
PaganoGPaciniGMussoG, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology2002; 35(2): 367–372.
11.
GaeiniZBahadoranZMirmiranP, et al. The association between liver function tests and some metabolic outcomes: tehran lipid and Glucose Study. Hepatitis Monthly2020; 20(5): e98535.
12.
KimHRHanMA.Association between serum liver enzymes and metabolic syndrome in Korean adults. Int J Environ Res Public Health2018; 15(8): 1658.
13.
ZhangLMaXJiangZ, et al. Liver enzymes and metabolic syndrome: a large-scale case-control study. Oncotarget2015; 26782(29): 6.
14.
NannipieriMGonzalesCBaldiS, et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care2005; 28(7): 1757–1762.
15.
LeeKYangJH.Which liver enzymes are better indicators of metabolic syndrome in adolescents: the Fifth Korea National Health and Nutrition Examination Survey, 2010. Metab Syndr Relat Disord2013; 11(4): 229–235.
PoustchiHEghtesadSKamangarF, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol2018; 187(4): 647–55.
18.
HakimiHAhmadiJVakilianA, et al. The profile of Rafsanjan cohort study. Eur J Epidemiol2021; 36(2): 243–252.
19.
RezaeiMFakhriNPasdarY, et al. Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study. Lipids Health Dis2020; 19(1): 1–8.
20.
DalvandSNiksimaSHMeshkaniR, et al. Prevalence of metabolic syndrome among Iranian population: a systematic review and meta-analysis. Iran J Public Health2017; 46(4): 456.
21.
PereraSLohsoonthornVJiamjarasrangsiW, et al. Association between elevated liver enzymes and metabolic syndrome among Thai adults. Diabetes Metab Syndr Clin Res Rev2008; 2(3): 171–178.
22.
TakiKNishioKHamajimaN, et al. Metabolic syndrome defined by new criteria in Japanese is associated with increased liver enzymes and C-reactive protein. Nagoya J Med Sci2008; 70(1/2): 1.
23.
HanleyAJWilliamsKFestaA, et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes2004; 53(10): 2623–2632.
24.
WangSZhangJZhuL, et al. Association between liver function and metabolic syndrome in Chinese men and women. Sci Rep2017; 7(1): 1–9.
25.
BallestriSZonaSTargherG, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol2016; 31(5): 936–944.
26.
HanleyAJWilliamsKFestaAWagenknechtLE, et al. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes2005; 54(11): 3140–3147.
27.
MarchesiniGBriziMBianchiG, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes2001; 50(8): 1844–1850.
28.
TarantinoGCaputiA.JNKs, insulin resistance and inflammation: a possible link between NAFLD and coronary artery disease. World J Gastroenterol2011; 17(33): 3785.
29.
ShioiAKatagiMOkunoY, et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-α and oncostatin M derived from macrophages. Circ Res2002; 91(1): 9–16.
